购物车
- 全部删除
- 您的购物车当前为空
Tasisulam (LY573636) 是一种小分子抗肿瘤药物,通过内在途径诱导细胞凋亡,导致细胞色素 c 释放和 caspase 依赖性细胞死亡。它抑制有丝分裂进程并诱导血管正常化。
Tasisulam (LY573636) 是一种小分子抗肿瘤药物,通过内在途径诱导细胞凋亡,导致细胞色素 c 释放和 caspase 依赖性细胞死亡。它抑制有丝分裂进程并诱导血管正常化。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 149 | 现货 | |
5 mg | ¥ 332 | 现货 | |
10 mg | ¥ 533 | 现货 | |
25 mg | ¥ 1,190 | 现货 | |
50 mg | ¥ 1,980 | 现货 | |
100 mg | ¥ 2,960 | 现货 | |
200 mg | ¥ 4,360 | 现货 | |
500 mg | ¥ 6,780 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 516 | 现货 |
产品描述 | Tasisulam (LY573636) is an apoptosis inducer and an antitumor agent via the intrinsic pathway. |
体外活性 | Tasisulam在多种人类白血病和淋巴瘤细胞系中抑制生长,ED50值介于7至40μM之间。LY573636还通过丧失线粒体膜电位和诱导活性氧种类的产生,在HL60、Reh和MD901细胞中诱导凋亡。[1]此外,Tasisulam在测试的120种细胞系中70%以上显示出抗增殖活性,EC50值小于50μM。Tasisulam在Calu-6和A-375细胞中诱导G2-M堆积及随后的凋亡。在体外,Tasisulam还能抑制由VEGF、FGF和EGF诱导的内皮细胞索形成,其EC50值分别为47、103和34nM。[2] |
体内活性 | Tasisulam在活体内诱导血管正常化的形态特征,包括提高脉络膜细胞覆盖率和降低低氧状态。Tasisulam(25或50 mg/kg, i.v.)显示出剂量依赖性的抗肿瘤活性,能够诱导凋亡并正常化与Calu-6非小细胞肺癌异种移植模型相关的血管。此外,Tasisulam在多种活体内异种移植模型中显示出强大的抗肿瘤活性,包括结直肠癌(HCT-116)、黑色素瘤(A-375)、胃癌(NUGC-3)、白血病(MV-4-11)和胰腺癌(QGP-1)。[2] |
激酶实验 | Electrophysiology: The human IKCa1 is cloned and expressed in COS-7 cells. Cells are studied in the whole-cell configuration of the patch-clamp technique. The holding potential is 280 mV. The internal pipette solution contains: 145 mM K+ aspartate, 2 mM MgCl2, 10 mM Hepes, 10 mM K2EGTA, and 8.5 mM CaCl2 (1 μM free Ca2+), pH 7.2, 290-310 mOsm. To reduce currents from the native chloride channels in COS-7 cells, Na+ aspartate Ringer is used as an external solution: 160 mM Na+ aspartatey/4.5 mM KCl/2 mM CaCl2/1 mM MgCl2/5 mM Hepes, pH 7.4/290-310 mOsm. IKCa currents in COS-7 cells are elicited by 200-ms voltage ramps from -120 mV to 40 mV applied every 10 seconds and the reduction of slope conductance at -80 mV by TRAM-34 taken as a measure of channel block. |
细胞实验 | Cells are treated with various concentrations of LY573636. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay is performed. Briefly, MTT is dissolved in phosphate-buffered saline (PBS) at 5 mg/mL. Approximately 1,000 cells per well are incubated in culture medium for 96 hours in 96-well plates; and then, 10 μL of the MTT solution is added. After a 4-hour incubation, 100 μL of solubilization solution (20 % sodium dodecyl sulfate [SDS]) is added, and the mixture was incubated at 37 °C for 16 hours. In this assay, MTT is cleaved to an orange formazan dye by metabolically active cells; and the absorbance of the formazan product is measured with an enzyme-linked immunoabsorbent assay (ELISA) reader at 540 nm. (Only for Reference) |
别名 | 他司磺胺, LY573636 |
分子量 | 415.11 |
分子式 | C11H6BrCl2NO3S2 |
CAS No. | 519055-62-0 |
Smiles | Clc1ccc(C(=O)NS(=O)(=O)c2ccc(Br)s2)c(Cl)c1 |
密度 | 1.812 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | Ethanol: 77 mg/mL (185.5 mM) DMSO: 77 mg/mL (185.5 mM) H2O: < 1 mg/mL (insoluble or slightly soluble) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容